Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Thursday - 20 June 2024

Thursday, 20 June 2024

Ceisteanna (205)

Michael Healy-Rae

Ceist:

205. Deputy Michael Healy-Rae asked the Minister for Health the reason pegvaliase, a game-changing medicine for a handful of phenylketonuria patients, has taken more than four years to go through the various stages of the HSE's appraisal process (details supplied); where this currently is in the system; the other steps required; when they will be completed; and if he will make a statement on the matter. [26584/24]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Roinn